HUP0102117A2 - Imidazo[1,2-a]pyridine derivatives and pharmaceutical compositions thereof - Google Patents
Imidazo[1,2-a]pyridine derivatives and pharmaceutical compositions thereofInfo
- Publication number
- HUP0102117A2 HUP0102117A2 HU0102117A HUP0102117A HUP0102117A2 HU P0102117 A2 HUP0102117 A2 HU P0102117A2 HU 0102117 A HU0102117 A HU 0102117A HU P0102117 A HUP0102117 A HU P0102117A HU P0102117 A2 HUP0102117 A2 HU P0102117A2
- Authority
- HU
- Hungary
- Prior art keywords
- imidazo
- pharmaceutical compositions
- pyridine derivatives
- pyridine
- derivatives
- Prior art date
Links
- 150000005234 imidazo[1,2-a]pyridines Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1998/010299 WO1999059587A1 (en) | 1998-05-20 | 1998-05-20 | Anti-viral compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0102117A2 true HUP0102117A2 (en) | 2001-12-28 |
Family
ID=22267098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0102117A HUP0102117A2 (en) | 1998-05-20 | 1998-05-20 | Imidazo[1,2-a]pyridine derivatives and pharmaceutical compositions thereof |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1077701A4 (en) |
| JP (1) | JP2002515433A (en) |
| KR (1) | KR20010025055A (en) |
| CN (1) | CN1292697A (en) |
| AU (1) | AU7583098A (en) |
| BR (1) | BR9815899A (en) |
| CA (1) | CA2332403A1 (en) |
| CZ (1) | CZ289425B6 (en) |
| EA (1) | EA200001208A1 (en) |
| HU (1) | HUP0102117A2 (en) |
| IL (1) | IL139166A0 (en) |
| NO (1) | NO20005795L (en) |
| SK (1) | SK17482000A3 (en) |
| TR (1) | TR200003414T2 (en) |
| WO (1) | WO1999059587A1 (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPR213700A0 (en) | 2000-12-18 | 2001-01-25 | Biota Scientific Management Pty Ltd | Antiviral agents |
| AR048650A1 (en) * | 2004-05-04 | 2006-05-10 | Tibotec Pharm Ltd | DERIVATIVES OF (1,10B-DIHIDRO-2- (AMINOCARBONIL-PHENYL) -5H-PIRAZOLO [1,5 C] [1,3] BENZOXAZIN-5-IL) METHANONE PHENYL AS INHIBITORS OF HIV VIRAL REPLICATION |
| DE602005020313D1 (en) | 2004-08-12 | 2010-05-12 | Amgen Inc | Bis-aryl SULPHONAMIDES |
| US7666880B2 (en) | 2005-03-21 | 2010-02-23 | S*Bio Pte Ltd. | Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications |
| TW200714600A (en) * | 2005-03-21 | 2007-04-16 | S Bio Pte Ltd | Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| WO2007076035A2 (en) | 2005-12-21 | 2007-07-05 | Abbott Laboratories | Anti-viral compounds |
| ES2378473T3 (en) | 2005-12-21 | 2012-04-12 | Abbott Laboratories | Antiviral compounds |
| ES2395386T3 (en) | 2005-12-21 | 2013-02-12 | Abbott Laboratories | Antiviral compounds |
| WO2008133753A2 (en) | 2006-12-20 | 2008-11-06 | Abbott Laboratories | Anti-viral compounds |
| EP2297141B1 (en) * | 2008-05-27 | 2015-10-21 | Biota Scientific Management Pty Ltd | Antiviral salts |
| EP2367823A1 (en) | 2008-12-23 | 2011-09-28 | Abbott Laboratories | Anti-viral compounds |
| ES2567047T3 (en) | 2008-12-23 | 2016-04-19 | Abbvie Inc. | Anti-viral pyrimidine derivatives |
| CA2758484A1 (en) | 2009-04-15 | 2010-10-21 | David A. Degoey | Anti-viral compounds |
| WO2014060381A1 (en) | 2012-10-18 | 2014-04-24 | Bayer Cropscience Ag | Heterocyclic compounds as pesticides |
| WO2014067962A1 (en) | 2012-10-31 | 2014-05-08 | Bayer Cropscience Ag | Novel heterocyclic compounds as pest control agents |
| CN104370732B (en) * | 2014-01-26 | 2015-08-19 | 山东信立泰药业有限公司 | The preparation method of a kind of clopidogrel and intermediate thereof |
| CN109535405B (en) * | 2017-09-21 | 2021-07-30 | 宁波聚嘉新材料科技有限公司 | Preparation method of polyarylate based on 2- (4-carboxyphenyl) -5-hydroxypyridoimidazole |
| CN109810085B (en) * | 2019-04-19 | 2019-07-19 | 上海皓元生物医药科技有限公司 | The preparation method of ACC inhibitor and its intermediate |
| CN110746450A (en) * | 2019-09-17 | 2020-02-04 | 济南康和医药科技有限公司 | Synthetic method of beraprost sodium key intermediate |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4096264A (en) * | 1975-12-09 | 1978-06-20 | Merck & Co., Inc. | Certain substituted imidazo [1,2-a] pyridines |
| US4250174A (en) * | 1979-05-02 | 1981-02-10 | Merck & Co., Inc. | 3-Substituted imidazo [1,2-A] pyridines |
| US5693661A (en) * | 1995-06-07 | 1997-12-02 | Eli Lilly And Company | Anti-viral compounds |
| US5891874A (en) * | 1996-06-05 | 1999-04-06 | Eli Lilly And Company | Anti-viral compound |
| CA2257296A1 (en) * | 1996-06-05 | 1997-12-11 | Mark Joseph Tebbe | Anti-viral compounds |
| US5821242A (en) * | 1996-06-06 | 1998-10-13 | Eli Lilly And Company | Anti-viral compounds |
-
1998
- 1998-05-20 AU AU75830/98A patent/AU7583098A/en not_active Abandoned
- 1998-05-20 IL IL13916698A patent/IL139166A0/en unknown
- 1998-05-20 JP JP2000549252A patent/JP2002515433A/en not_active Withdrawn
- 1998-05-20 CZ CZ20004278A patent/CZ289425B6/en unknown
- 1998-05-20 CN CN988140519A patent/CN1292697A/en active Pending
- 1998-05-20 HU HU0102117A patent/HUP0102117A2/en unknown
- 1998-05-20 WO PCT/US1998/010299 patent/WO1999059587A1/en not_active Application Discontinuation
- 1998-05-20 EP EP98923565A patent/EP1077701A4/en not_active Withdrawn
- 1998-05-20 TR TR2000/03414T patent/TR200003414T2/en unknown
- 1998-05-20 EA EA200001208A patent/EA200001208A1/en unknown
- 1998-05-20 SK SK1748-2000A patent/SK17482000A3/en unknown
- 1998-05-20 CA CA002332403A patent/CA2332403A1/en not_active Abandoned
- 1998-05-20 KR KR1020007012999A patent/KR20010025055A/en not_active Application Discontinuation
- 1998-05-20 BR BR9815899-6A patent/BR9815899A/en not_active IP Right Cessation
-
2000
- 2000-11-16 NO NO20005795A patent/NO20005795L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20005795L (en) | 2001-01-18 |
| KR20010025055A (en) | 2001-03-26 |
| SK17482000A3 (en) | 2005-03-04 |
| TR200003414T2 (en) | 2001-03-21 |
| EA200001208A1 (en) | 2001-06-25 |
| CA2332403A1 (en) | 1999-11-25 |
| NO20005795D0 (en) | 2000-11-16 |
| IL139166A0 (en) | 2001-11-25 |
| CN1292697A (en) | 2001-04-25 |
| WO1999059587A1 (en) | 1999-11-25 |
| EP1077701A4 (en) | 2002-03-20 |
| CZ289425B6 (en) | 2002-01-16 |
| EP1077701A1 (en) | 2001-02-28 |
| BR9815899A (en) | 2001-02-20 |
| AU7583098A (en) | 1999-12-06 |
| JP2002515433A (en) | 2002-05-28 |
| CZ20004278A3 (en) | 2001-05-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL191960A (en) | Imidazo[1,5-a]pyridine derivatives and pharmaceutical compositions comprising the same | |
| HUP0103472A3 (en) | Pyrrolo[2,3-d]pyrimidine derivatives and pharmaceutical compositions containing the same | |
| HUP0102313A3 (en) | Imidazo pyridine derivatives, process for their preparation pharmaceutical compositions containing the same and intermediates | |
| HUP0100179A3 (en) | Imidazopyrimidine and imidazopyridine derivatives and pharmaceutical compositions thereof | |
| HUP0200207A3 (en) | Substituted 2-aryl-3-(hetroaryl)-imidazo [1,2-a] pyrimidines, and related pharmaceutical compositions and methods for their preparation | |
| IL134688A (en) | CYCLOOXYGENASE 2 INHIBITING 2, 3-DIARYL-PYRAZOLO [1, 5-b] PYRIDAZINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| HUP0202494A3 (en) | Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives, process for their preparation and pharmaceutical compositions containing them | |
| AU7922900A (en) | Thiazole and imidazo (4,5-b) pyridine compounds and their pharmaceutical use | |
| HUP0103921A3 (en) | [1,2,4]triazolo[1,5-c]pyrimidine derivatives and pharmaceutical compositions thereof | |
| HK1024914A1 (en) | 1,2,4-triazolo 4,3-b]pyrido 3,2-d]pyridazine derivatives and pharmaceutical compositions containing them | |
| HUP9800138A3 (en) | 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives, process for producing them, pharmaceutical compositions containing the same and their use | |
| HUP0102117A2 (en) | Imidazo[1,2-a]pyridine derivatives and pharmaceutical compositions thereof | |
| HUP0000720A3 (en) | Imidazo [1,2-a] pyridine derivatives, process for their preparation, pharmaceutical formulation containing them and their use | |
| NZ322197A (en) | Pyrido[2,3-d] pyrimidine derivatives and pharmaceutical compositions thereof | |
| HUP0002902A3 (en) | 3-substituted 3,4 dyhydro-thieno[2,3-d]pyrimidine derivatives and their use for the preparation of pharmaceutical compositions | |
| HUP0102585A3 (en) | Thienylazolylalcoxyethanamin derivatives preparation the same and their use as medicaments | |
| HUP0003826A3 (en) | Novel triazolo [4,5-b] pyrimidine derivatives, process for their preparation and pharmaceutical compositions thereof | |
| HUP0102981A3 (en) | Pyrrolo[1,2-a]pyrazine derivatives and pharmaceutical compositions thereof | |
| NZ241943A (en) | PYRROLO [2,3-b] PYRIDINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS | |
| HUP0104164A3 (en) | Imidazo[4,5-c]-pyridine-4-one derivatives with factor xa inhibiting effect, pharmaceutical compositions containing the same and process for their preparation | |
| HUP0105054A3 (en) | Imidazo[4,5-c]-pyridine-4-on-derivatives, pharmaceutical compositions containing them and process for their preparation | |
| NZ314497A (en) | Pyrimido[1,2-a]indoles, intermediate and pharmaceutical compositions | |
| HUP0004648A3 (en) | 3-substituted tetrahydropyridopyrimidinone derivatives and their use for producing pharmaceutical compositions | |
| AU2141695A (en) | Imidazo{1,2-a}pyrazine-4-one derivatives, preparation thereof and drugs containing same | |
| HUP0101508A3 (en) | Isoxazolo[3,4-c]quinoline derivatives, their use and pharmaceutical compositions containing them |